Post by Teleon

#LENSAR Announces Application for Certification of the #ALLY™ Adaptive Cataract Treatment System in the EU “Following the FDA clearance of ALLY in June 2022 and recent U.S. commercial launch, this is another important step in our effort to bring ALLY to cataract surgeons in key global markets. Our mission has always been to create a platform that optimizes the way premium cataract surgeries are performed, and we believe that ALLY addresses all limitations of current competitive technologies.” said Nick Curtis, Chief Executive Officer of LENSAR.   ALLY enables surgeons to complete a femtosecond-laser-assisted cataract surgery (“#FLACS”) procedure seamlessly in a single, sterile environment and provide Adaptive Intelligence™ to automatically determine #cataract density, optimize fragmentation patterns, and energy settings. Book your live-Demo presentation at the #Teleon #ESCRS2022 booth and save your timeslot: https://lnkd.in/emMH6R_Y   LENSAR press release: https://lnkd.in/er9YjUg2